PDF 1.516kB - TOBIAS-lib - Universität Tübingen

Literaturverzeichnis
Mariya Gosheva
98. Zürn, CS, Geisler, T, Paterok, M and Gawaz, M. Influence of statins on the
antiplatelet effect of clopidogrel and on cardiovaskucular outcome in patients
after coronary intervention. Dtsch Med Wochenschr. 2008, 133: 817-822.
99. Geisler, T, Anders, N, Paterok, M, Langer, H, Stellos, K, Lindemann, S,
Herdeg, C, May, AE and Gawaz, M. Platelet response to clopidogrel is
attenuated in diabetic patients undergoing coronary stent implantation. Diabetes
Care. 2007, 30: 372-374.
100. Angiolillo, DJ, Fernandez-Ortiz, A, Bernardo, E, Ramirez, C, Sabate,
M, Jimenez-Quevedo, P, Hernandez, R, Moreno, R, Escaned, J, Alfonso, F,
Banuelos, C, Costa, MA, Bass, TA and Macaya, C. Platelet functions profiles
in patients with type 2 diabetes and coronary artery desease on compined
aspirin and clopidogrel treatment. Diabetes. 2005, 54: 2430-2435.
101. von Beckerath, N, Taubert, D, Pogatsa-Murray, G, Schömig, E,
Kastrati, A and Schömig, A. Absorption, metabolization and antiplatelet
effects of 300-, 600- and 900-mg of loading dose Clopidogrel:results of the
ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen:Choose
Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation.
2005, 112: 2946-2950.
102. Montalescot, G, Sideris, G, Meuleman, C, Bal-dit-Sollier, C, Lellouche,
N, Steg, PG, Slama, M, Milleron, O, Collet, JP, Henry, P, Beygui, F, Drouet,
L and ALBION Trial Investigators. A randomized comparison of high
clopidogrel loading doses in patients with non-ST-segment elevation acute
coronary syndroms: the ALBION (Assessment of the Best Loading Dose of
Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) . J
Am Coll Cardiol. 2006, 48: 931-938.
- 67 -